Augmenting care in hepatocellular carcinoma with artificial intelligence

Abstract

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide and prognosis remains poor. The recent paradigm shifts in management algorithms of such patients have resulted in unique challenges in the early identification of HCC, prognosis, surgical outcomes, prioritization of potential transplant recipients, donor-recipient matching, and so on. In recent years, advancements in artificial intelligence (AI) capabilities have shown potential in HCC treatment.

In this narrative review, we outline first the different types of AI models that are applied in clinical practice and then focus on the frontiers of AI research in the diagnosis, prognostication, and treatment of HCC, particularly in classification of indeterminate liver lesions, tumor staging, survival prediction, improving equity in transplant recipient selection, prediction of treatment response and prognosis. We show that US coupled with AI-driven predictive models can provide accurate noninvasive screening tools for early disease. While AI models applied to contrast-enhanced CT, MRI and PET studies may appear to have limited clinical utility in disease diagnosis and differentials, owing to their accuracy, we highlighted the importance of such models in predicting pathological findings preoperatively. Despite the availability of many accurate, sensitive, and specific AI algorithms that outperform traditional scoring systems, they have not been widely used in clinical practice. The challenges in AI application, including distributional shift and imbalanced data, lack of standardization, and the ‘black box’ phenomenon, are addressed here. The importance of AI in the future of HCC makes it important for clinicians to have a good understanding of different AI techniques, their benefits, and potential pitfalls.

Keywords

Hepatocellular cancer / liver cancer / liver imaging / liver surgery / artificial intelligence / machine learning / neural network

References

[1] Llovet JM,Villanueva A.Hepatocellular carcinoma.Nat Rev Dis Primers2021;7:6

[2] Reig M,Rimola J.BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.J Hepatol2022;76:681-93

[3] Finn RS,Ikeda M.IMbrave150 investigatorsatezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.N Engl J Med2020;382:1894-905

[4] Brar G,Graubard BI.Hepatocellular carcinoma survival by etiology: a seer-medicare database analysis.Hepatol Commun2020;4:1541-51 PMCID:PMC7527688

[5] Yang JD.Detect or not to detect very early-stage hepatocellular carcinoma?.Clin Mol Hepatol2019;25:335-43

[6] SD; British society of gastroenterology. guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.Gut2003;52 Suppl 3:iii1-8

[7] Best J,Bechmann LP.Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma.HR2020;2020

[8] Simmons O,Yokoo T.Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.Aliment Pharmacol Ther2017;45:169-77 PMCID:PMC7207219

[9] Mazzaferro V,Doci R.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med1996;334:693-9

[10] Massad E.Liver tumors and liver transplantation. Elsevier; 2020. pp. 97-115.

[11] Burak KW.Prognosis in the early stages of hepatocellular carcinoma: predicting outcomes and properly selecting patients for curative options.Can J Gastroenterol2011;25:482-4 PMCID:PMC3202354

[12] Farinati F,Baldan A.Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter?.BMC Cancer2009;9:33 PMCID:PMC2640412

[13] Kim HY,Nam JY.An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.J Hepatol2022;76:311-8

[14] Bharti P,Ananthasivan R.Preliminary study of chronic liver classification on ultrasound images using an ensemble model.Ultrason Imaging2018;40:357-79

[15] Schmauch B,Jehanno P.Diagnosis of focal liver lesions from ultrasound using deep learning.Diagn Interv Imaging2019;100:227-33

[16] Mokrane FZ,Vavasseur A.Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.Eur Radiol2020;30:558-70

[17] Jansen MJA,Veldhuis WB,Viergever MA.Automatic classification of focal liver lesions based on MRI and risk factors.PLoS One2019;14:e0217053 PMCID:PMC6522218

[18] Zhang F,Nezami N.Liver tissue classification using an auto-context-based deep neural network with a multi-phase training framework. In: Bai W, Sanroma G, Wu G, Munsell BC, Zhan Y, Coupé P, editors. patch-based techniques in medical imaging. cham: springer international publishing; 2018. pp.59-66. PMCID:PMC7236808

[19] Kiani A,Rajpurkar P.Impact of a deep learning assistant on the histopathologic classification of liver cancer.NPJ Digit Med2020;3:23.

[20] Liao H,Han R.Deep learning-based classification and mutation prediction from histopathological images of hepatocellular carcinoma.Clin Transl Med2020;10:e102. PMCID:PMC7403820

[21] Sun SW,Liu QP.LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.Med Phys2022;49:6903-13

[22] Noh B,Kwon Y.Machine learning-based survival rate prediction of Korean hepatocellular carcinoma patients using multi-center data.BMC Gastroenterol2022;22:85 PMCID:PMC8882306

[23] Simsek C,Koray Sahin T.Artificial intelligence method to predict overall survival of hepatocellular carcinoma.Hepatol Forum2021;2:64-8 PMCID:PMC9138921

[24] Mähringer-Kunz A,Hahn F.Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: a pilot study.Liver Int2020;40:694-703

[25] Saillard C,Laifa O.Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides.Journal of Hepatology2020;73:S381

[26] Liang JD,Tseng YJ,Lai F.Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods.Meth Pro2014;117:425-34

[27] Janiesch C,Heinrich K.Machine learning and deep learning.Electron Markets2021;31:685-95

[28] Jiang T,Rosellini AJ.Supervised machine learning: a brief primer.Behav Ther2020;51:675-87 PMCID:PMC7431677

[29] Ghahramani Z.Unsupervised learning. in: bousquet o, von luxburg u, rätsch g, editors. advanced lectures on machine learning. berlin: springer berlin heidelberg; 2004. pp.72-112.

[30] Sarker IH.Deep learning: a comprehensive overview on techniques, taxonomy, applications and research directions.SN Comput Sci2021;2:420 PMCID:PMC8372231

[31] Han SH,Kim S.Artificial neural network: understanding the basic concepts without mathematics.Dement Neurocogn Disord2018;17:83-9 PMCID:PMC6428006

[32] Pai A. CNN vs. RNN vs. ANN – analyzing 3 types of neural networks in deep learning. Available from: https://www.analyticsvidhya.com/blog/2020/02/cnn-vs-rnn-vs-mlp-analyzing-3-types-of-neural-networks-in-deep-learning/ [Last accessed on 23 Mar 2023]

[33] Indolia S,Mishra S.Conceptual understanding of convolutional neural network- a deep learning approach.Procedia Computer Science2018;132:679-88

[34] Marhon SA,Kremer SC.Recurrent neural networks. in: bianchini m, maggini m, jain lc, editors. handbook on neural information processing. berlin: springer berlin heidelberg; 2013.p.29-65.

[35] Savage N.Breaking into the black box of artificial intelligence.Nature2022;

[36] Chartrand G,Vorontsov E.Deep learning: a primer for radiologists.Radiographics2017;37:2113-31

[37] Azer SA.Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: a systematic review.World J Gastrointest Oncol2019;11:1218-30 PMCID:PMC6937442

[38] Liu X,Wang SH,Chen YQ.Learning to diagnose cirrhosis with liver capsule guided ultrasound image classification.Sensors2017;17:149 PMCID:PMC5298722

[39] Książek W,Acharya UR.A novel machine learning approach for early detection of hepatocellular carcinoma patients.Csri2019;54:116-27

[40] Brehar R,Vancea F.Comparison of deep-learning and conventional machine-learning methods for the automatic recognition of the hepatocellular carcinoma areas from ultrasound images.Sensors2020;20:3085 PMCID:PMC7309124

[41] Guo LH,Qian YY.A two-stage multi-view learning framework based computer-aided diagnosis of liver tumors with contrast enhanced ultrasound images.Clin Hemorheol Microcirc2018;69:343-54

[42] Yang Q,Hao X.Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: a multicentre study.EBioMedicine2020;56:102777 PMCID:PMC7262550

[43] Streba CT,Gheonea DI.Contrast-enhanced ultrasonography parameters in neural network diagnosis of liver tumors.World J Gastroenterol2012;18:4427-34 PMCID:PMC3436061

[44] Hassan TM,Sallam E.Diagnosis of focal liver diseases based on deep learning technique for ultrasound images.Arab J Sci Eng2017;42:3127-40

[45] Shi W,Cao S.Deep learning assisted differentiation of hepatocellular carcinoma from focal liver lesions: choice of four-phase and three-phase CT imaging protocol.Abdom Radiol2020;45:2688-97

[46] Yasaka K,Abe O.Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced ct: a preliminary study.Radiology2018;286:887-96

[47] Hamm CA,Savic LJ.Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI.Eur Radiol2019;29:3338-47 PMCID:PMC7251621

[48] Preis O,Scott JA.Neural network evaluation of PET scans of the liver: a potentially useful adjunct in clinical interpretation.Radiology2011;258:714-21

[49] Tunissiolli NM,Biselli-Chicote PM.Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy.Asian Pac J Cancer Prev2017;18:863-72 PMCID:PMC5494234

[50] Yeom SK,Cha SH.Prediction of liver cirrhosis, using diagnostic imaging tools.World J Hepatol2015;7:2069-79 PMCID:PMC4539400

[51] association for the study of the liver. electronic address: [e-mail], European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma.J Hepatol2018;69:182-236

[52] Tanaka H.Current role of ultrasound in the diagnosis of hepatocellular carcinoma.J Med Ultrason2020;47:239-55 PMCID:PMC7181430

[53] Bhogadi Y,Lee SY.Contrast-enhanced ultrasound in the diagnosis of infiltrative hepatocellular carcinoma: a report of three cases.Radiol Case Rep2021;16:448-56 PMCID:PMC7753068

[54] Shen J,Li C.The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.BMC Cancer2018;18:278 PMCID:PMC5848587

[55] Jiang YQ,Cao S.Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning.J Cancer Res Clin Oncol2021;147:821-33 PMCID:PMC7873117

[56] Zhang Y,Qiu J.Deep learning with 3D convolutional neural network for noninvasive prediction of microvascular invasion in hepatocellular carcinoma.J Magn Reson Imaging2021;54:134-43

[57] Liu F,Wang K.Deep learning radiomics based on contrast-enhanced ultrasound might optimize curative treatments for very-early or early-stage hepatocellular carcinoma patients.Liver Cancer2020;9:397-413

[58] Zhang L,Yan ZP.Deep learning predicts overall survival of patients with unresectable hepatocellular carcinoma treated by transarterial chemoembolization plus sorafenib.Front Oncol2020;10:593292 PMCID:PMC7556271

[59] Gotra A,Chartrand G.Liver segmentation: indications, techniques and future directions.Insights Imaging2017;8:377-92 PMCID:PMC5519497

[60] Al-kababji A,Dakua SP.Automated liver tissues delineation techniques: a systematic survey on machine learning current trends and future orientations.Eng Appl Artif Intell2023;117:105532

[61] Liang F,Su KH.Abdominal, multi-organ, auto-contouring method for online adaptive magnetic resonance guided radiotherapy: An intelligent, multi-level fusion approach.Artif Intell Med2018;90:34-41

[62] Gibson E,Hu Y.Automatic multi-organ segmentation on abdominal CT with dense v-networks.IEEE Trans Med Imaging2018;37:1822-34 PMCID:PMC6076994

[63] Llovet JM,Heikenwalder M.Immunotherapies for hepatocellular carcinoma.Nat Rev Clin Oncol2022;19:151-72.

[64] Muhammed A,Enica A.Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma.Expert Rev Mol Diagn2022;22:253-64

[65] He Y,Che J,Zhang P.Biomarkers and future perspectives for hepatocellular carcinoma immunotherapy.Front Oncol2021;11:716844

[66] Ji GW,Xu Q.Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.EBioMedicine2019;50:156-65 PMCID:PMC6923482

[67] Saillard C,Laifa O.Predicting survival after hepatocellular carcinoma resection using deep learning on histological slides.Hepatology2020;72:2000-13

[68] Malinchoc M,Gordon FD,Rank J.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatology2000;31:864-71

[69] Kamath PS,Malinchoc M.A model to predict survival in patients with end-stage liver disease.Hepatology2001;33:464-70

[70] Bertsimas D,Trichakis N,Hirose R.Development and validation of an optimized prediction of mortality for candidates awaiting liver transplantation.Am J Transplant2019;19:1109-18

[71] Yu YD,Man Kim J.Korean organ transplantation registry study groupArtificial intelligence for predicting survival following deceased donor liver transplantation: Retrospective multi-center study.Int J Surg2022;105:106838

[72] Briceño J,Prieto M.Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study.J Hepatol2014;61:1020-8

[73] Guijo-Rubio D,Gutiérrez PA,Ciria R.Statistical methods versus machine learning techniques for donor-recipient matching in liver transplantation.PLoS One2021;16:e0252068 PMCID:PMC8139468

[74] Peng J,Ning Z.Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.Eur Radiol2020;30:413-24 PMCID:PMC6890698

[75] Morshid A,Khalaf AM.A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization.Radiol Artif Intell2019;1:e180021 PMCID:PMC6920060

[76] Liu D,Xie X.Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.Eur Radiol2020;30:2365-76

[77] Kant I. Critique of Pure Reason. Available from: https://play.google.com/store/books [Last accessed on 23 Mar 2023]

[78] Jumper J,Pritzel A.Highly accurate protein structure prediction with AlphaFold.Nature2021;596:583-9 PMCID:PMC8371605

[79] Stokes JM,Swanson K.A deep learning approach to antibiotic discovery.Cell2020;180:688-702.e13

[80] Marwaha JS.Crossing the chasm from model performance to clinical impact: the need to improve implementation and evaluation of AI.NPJ Digit Med2022;5:25 PMCID:PMC8894388

[81] Jiang L,Xu X.Opportunities and challenges of artificial intelligence in the medical field: current application, emerging problems, and problem-solving strategies.J Int Med Res2021;49:3000605211000157 PMCID:PMC8165857

[82] Chan KS.Applications and challenges of implementing artificial intelligence in medical education: integrative review.JMIR Med Educ2019;5:e13930 PMCID:PMC6598417

[83] FDA. Current good manufacturing practice (CGMP) regulations. Available from: https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations [Last accessed on 23 Mar 2023]

[84] Dockès J,Poline JB.Preventing dataset shift from breaking machine-learning biomarkers.Gigascience2021;10 PMCID:PMC8478611

[85] Haixiang G,Shang J,Yuanyue H.Learning from class-imbalanced data: Review of methods and applications.Expert Systems with Applications2017;73:220-39

[86] Storkey AJ. When training and test sets are different: characterising learning transfer. Available from:https://homepages.inf.ed.ac.uk/amos/publications/Storkey2009TrainingTestDifferent.pdf [Last accessed on 23 Mar 2023]

[87] Shah NH,Bagley PhD SC.Making machine learning models clinically useful.JAMA2019;322:1351-2

[88] Luo W,Tran T.Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view.J Med Internet Res2016;18:e323 PMCID:PMC5238707

[89] Mathrani A,Ramaswami G.Perspectives on the challenges of generalizability, transparency and ethics in predictive learning analytics.Comput Educ2021;2:100060

[90] Petch J,Nelson W.Opening the black box: the promise and limitations of explainable machine learning in cardiology.Can J Cardiol2022;38:204-13

[91] Suzuki K,Syeda-Mahmood T,Glocker B. Interpretability of machine intelligence in medical image computing and multimodal learning for clinical decision support: second international workshop, iMIMIC 2019, and 9th international workshop, ML-CDS 2019, held in conjunction with MICCAI 2019, Shenzhen, China, October 17, 2019, Proceedings. Available from: https://play.google.com/store/books/details?id=Vvm4DwAAQBAJ [Last accessed on 23 Mar 2023]

[92] Rudin C.Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead.Nat Mach Intell2019;1:206-15 PMCID:PMC9122117